secwatch.observer — SEC 8-K summary
======================================

Issuer:     Grace Therapeutics, Inc. (GRCE)
CIK:        0001444192
Form:       8-K
Filed at:   2023-03-13T23:59:59+00:00
Accession:  0000950170-23-007448
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Acasti voluntarily delists from TSX Venture; confirms no SVB/Silvergate exposure
--------------------------------------------------------------------------------

- Voluntary delisting from TSXV effective March 27, 2023; Nasdaq listing under ACST unaffected.
- Company cites low TSXV volume and high dual-listing costs; expects central Nasdaq marketplace to aid liquidity.
- Confirms no exposure to Silicon Valley Bank or Silvergate Bank; no deposits held at those institutions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1444192/000095017023007448/0000950170-23-007448-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1444192/000095017023007448/acst-20230313.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-007448

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer